William S. Dalton
William S. Dalton is the chair of the IHMC Board of Directors. He is also Founder and CEO of M2Gen®, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton received his Ph.D. in toxicology and medical life sciences and his M.D. degree from Indiana University. He is interested in developing approaches to enhance access to health care and developing evidence-based methods of evaluating and integrating new technologies into the standard of care.
Latest News
- IHMC open house unveils the robotics team’s new advanced humanoid Alex
- STEM-Talk: Tommy Wood discusses his new book and the adaptability of the aging brain
- STEM-Talk: Francisco Gonzalez-Lima on methylene blue and noninvasive brain stimulation
- STEM-Talk: Judith Curry and the Consequences of Climate Alarmism
- STEM-Talk: NASA’s Flawed Plan to Return to the Moon – with Mike Griffin and Lisa Porter
- IHMC partners with Conduit Venture Labs to accelerate commercialization efforts
- Research platforms aim to better support military personnel in high-stress environments
- Study for U.S. Air Force Research Lab tracks impact of ketones on pilot ventilation
- National Institute on Aging funded study tracks changes to gait as we age